Hydroxamates as therapeutic agents

Details for Australian Patent Application No. 2004230889 (hide)

Owner Pharmacyclics, Inc.

Inventors Robinson, James; Baskaran, Chitra; Verner, Eric J.; Buggy, Joseph J.; Sendzik, Martin

Agent Spruson & Ferguson

Pub. Number AU-B-2004230889

PCT Pub. Number WO2004/092115

Priority 60/461,286 07.04.03 US; 60/464,448 21.04.03 US

Filing date 6 April 2004

Wipo publication date 28 October 2004

Acceptance publication date 13 March 2008

International Classifications

C07C 259/10 (2006.01) Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups

A61K 31/18 (2006.01) - Sulfonamides

A61K 31/33 (2006.01) - Heterocyclic compounds

A61K 31/34 (2006.01) - having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide

A61K 31/4015 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide

A61K 31/4415 (2006.01) - Pyridoxine, i.e.vitamin B

A61K 41/00 (2006.01) Medicinal preparations obtained by treating materials with wave energy or particle radiation

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

C07D 207/12 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 207/327 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 207/34 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/08 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/18 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/42 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/44 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 211/46 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 213/56 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/74 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/81 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/82 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 215/08 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 215/18 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 215/48 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

Event Publications

13 October 2005 PCT application entered the National Phase

  PCT publication WO2004/092115 Priority application(s): WO2004/092115

24 January 2008 Assignment before Grant

  Axys Pharmaceuticals, Inc. The application has been assigned to Pharmacyclics, Inc.

13 March 2008 Application Accepted

  Published as AU-B-2004230889

10 July 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004230895-Derivatives of 2-(8,9-dioxo-2,6-diazabicyclo(5.2.0)non -1(7)-en-2-yl)alkyl phosphonic acid and their use as N-methyl-D-aspartate (NMDA) recetor antagonists

2004230871-Olivetol-cyclodextrin complexes and regio-selective process for preparing delta 9-tetrahydrocannabinol